Dexoligo Therapuetics

Dexoligo Therapeutics, a division of Dexcel Pharma, specializes in advancing RNA oligonucleotide therapies aimed at addressing critical clinical needs and enhancing patient lives. The company is driven by a team of dedicated scientists focused on developing innovative oligonucleotide drugs to tackle unmet medical challenges. With a commitment to le... veraging validated RNA drug modalities and novel technologies, Dexoligo aspires to lead in the field through a combination of biological insights and clinical expertise. Their core values emphasize innovation, professionalism, and a relentless pursuit of improvement.Read More